对影响新辅助疗法的敏感性病理因素的研究在下喉癌中
Gaofei Yin1, Nuan Li1, Xiaohong Chen1
1Beijing Tongren Hospital, Capital Medical University, NO1. Dongjiaomin Lane, Dongcheng District, 100730, Beijing, China.
Cancer immunology, immunotherapy : CII
|February 25, 2025
概括
阳性P53和低Ki67表达预测低反应的新辅助疗法在下甲状腺状细胞癌 (HSCC). P53阴性和高Ki67表明良好的反应,有助于治疗评估.
科学领域:
- 在瘤学瘤学.
- 头部和部癌症研究研究
- 生物标志物发现发现
背景情况:
- 低支柱状细胞癌 (HSCC) 是积极的,新辅助疗法改善了喉的保存.
- 在HSCC中预测新辅助疗法反应仍然具有挑战性.
- 确定可靠的预测生物标志物对于优化治疗策略至关重要.
研究的目的:
- 调查P53,P16,Ki67表达和新辅助疗法响应在HSCC患者之间的相关性.
- 为了确定预测治疗疗效的潜在生物标志物.
主要方法:
- 对120名接受新辅助治疗的HSCC患者的回顾性分析.
- 根据治疗反应和治疗类型对患者进行分组.
- 评估P53,P16和Ki67表达对治疗疗效的预测值.
主要成果:
- 与P53阴性 (66.07%) (p=0.0017) 相比,P53阳性 (35.94%) 与显著较低的响应率相关.
- 基67 < 60% (33.33%) 与显著低于基67 ≥ 60% (66.67%) (p=0.0005) 的响应率相关.
- P53阳性和Ki67<60%预测反应不佳,而P53阴性和Ki67≥60%预测良好反应.
结论:
- 在HSCC中,P53表达和Ki67水平是新辅助疗法反应的显著预测指标.
- 阳性P53和低Ki67表达表明对新辅助疗法的敏感性较低.
- 结合P53和P16的评估可以作为预测HSCC治疗疗效的初步工具,需要进一步调查P16的作用.
关键词:
下的平状细胞癌.在 Ki6767 的位置上.新辅助疗法是一种新辅助疗法.P16 P16 P16 P16 P16 P16 P16 P16 P16 P16 P16 P16 P16在P53中,P53是P53更多相关视频
08:59A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
Published on: January 5, 2017
10.6K
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
9.6K
相关概念视频
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
172
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
172
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
401
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
401
01:23Chronic Pharyngitis
892
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
892